Explore our core manufacturing formulations designed for global B2B distribution, private brand commercialization, and veterinary therapeutic applications.
A deep-dive technical overview on commercial formulation engineering, therapeutic efficacy, quality compliance, and European contract manufacturing architecture.
The global veterinary diets market is experiencing an unprecedented structural shift. Driven by advanced companion animal clinical diagnostics, rising pet humanization, and a growing awareness of chronic canine and feline pathological conditions—such as Chronic Kidney Disease (CKD), Gastrointestinal (GI) dysbiosis, Canine Atopic Dermatitis, feline lower urinary tract disease (FLUTD), and metabolic obesity—demand for specialized therapeutic pet food has expanded beyond classical veterinary clinics into direct-to-consumer premium health channels and specialized retail networks.
To succeed in today's competitive ecosystem, brand owners, clinical distributors, and multinational retail networks require more than standard co-packers. They require a vertically integrated OEM/ODM contract manufacturing partner capable of delivering precise therapeutic matrix formulations, rigorous raw material selection, advanced thermal and extrusion processing, and comprehensive European regulatory compliance.
Micro-targeted nutrient profiles engineered to support specific organ systems, metabolic recovery, and immune modulation under strict clinical guidelines.
Dual manufacturing capabilities in Spain and Ukraine, ensuring supply chain resilience, competitive production economics, and seamless EU export clearance.
Uncompromising feed safety assurance, pharmaceutical-grade line sanitization, complete lot traceability, and full compliance with EU Regulation (EC) No 767/2009.
Comprehensive biochemical mechanisms and nutritional engineering across primary therapeutic pet food categories.
Developing effective veterinary diets requires an exact balance of functional ingredients, bioavailable nutrients, and palatability enhancers. Unlike commercial maintenance foods, clinical diets act as functional management tools. Below is an in-depth breakdown of the main therapeutic categories produced within our European contract facilities:
Designed specifically to reduce workload on impaired kidneys and alter urinary pH to prevent urolithiasis (struvite and calcium oxalate crystal formation).
Engineered for pets presenting Adverse Food Reactions (AFR), cutaneous food allergies, and severe environmental inflammatory skin conditions.
Formulated for dogs and cats recovering from acute gastroenteritis, inflammatory bowel disease (IBD), exocrine pancreatic insufficiency (EPI), and dysbiosis.
Designed to induce safe adipose loss, manage postprandial blood glucose spikes, and maintain satiety in overweight or diabetic pets.
Emerging technologies, ingredient innovations, and market trajectories reshaping the global veterinary diets procurement sector over the next decade.
B2B procurement managers, brand founders, and corporate buyers must stay ahead of technological developments to maintain a market advantage. The veterinary pet food sector is undergoing a massive evolutionary upgrade driven by biotechnical innovation and changing consumer demands:
The traditional reliance on whole raw meat renderers is shifting toward precision-engineered bioactive hydrolysates. Through controlled enzymatic cleavage, manufacturers can produce targeted peptide sequences that act not just as basic amino acid sources, but as functional signaling molecules. These peptides exhibit anti-inflammatory, anti-hypertensive, and gut-soothing properties directly within the animal’s physiology.
Preserving heat-sensitive vitamins, active probiotics, and phytotherapeutics during industrial thermal processing is a primary goal for modern pet food engineers. Advanced dual-stage extrusion systems, operating at carefully calibrated Specific Mechanical Energy (SME) inputs, reduce thermal degradation. Furthermore, vacuum-coating technologies allow functional lipid layers and heat-sensitive bioactives to be infused deep into kibble matrix cores post-extrusion.
The boundary between strictly prescribed prescription diets and retail wellness diets is blurring. Pet owners increasingly seek "preventative clinical nutrition"—everyday foods enriched with therapeutic dosages of joint-protecting glycosaminoglycans (Glucosamine, Chondroitin, MSM), oral hygiene enzymes, and renal-supportive botanical extracts. OEM/ODM buyers are capitalizing on this trend by developing hybrid product ranges.
Sustainability is becoming a core requirement in B2B procurement evaluations. Insect meal (e.g., Hermetia illucens) and microalgae-derived Omega-3 oil (DHA/EPA) are transitioning from novel experiments into mainstream veterinary formulations. Insect protein provides a hypoallergenic, highly digestible protein source with an exceptionally low environmental footprint, ideal for therapeutic AFR formulations.
From raw formulation concept to final palletized global export—how we bring custom veterinary pet food recipes to market.
Nutrient matrix build against FEDIAF/AAFCO targets. Formulation, raw material spec, and cost modeling by staff nutritionists.
Small-batch extrusion or retort trial. Palatability checking, density verification, and lab analytical profile approval.
Full-scale batch mixing, double-twin extrusion, precise vacuum coating, or retort thermal sterilization under HACCP control.
Batch-level NIR analysis, heavy metal screening, microbiological safety checks (Salmonella zero-tolerance), and packaging integrity test.
TRACES certification, export documentation, health certificates, and multi-modal freight dispatch (Ex-Works, FCA, DAP).
Clear, authoritative answers to essential questions asked by sourcing directors, veterinary brand managers, and import buyers.
Production MOQs vary based on format and packaging specifications. For dry extruded kibble, initial custom formulation runs typically start at 1 full production batch (approx. 2 to 3 metric tons per SKU). For wet food pouches or cans, MOQs are determined by retort batch capacities (typically 3,000 to 5,000 units depending on pouch size). We also offer stock base recipes with lower MOQs for brand validation phases.
All single-protein and hydrolyzed therapeutic runs undergo strict, validated wet-cleaning and allergen decontamination protocols. Production schedules are grouped to isolate sensitive protein runs, and post-sanitization flushing logs along with rapid swab allergen testing ensure zero cross-contact prior to running sensitive diets.
Our dual facilities in Spain and Ukraine operate under strict International Featured Standard (IFS Food v8) high-level certification, Hazard Analysis Critical Control Point (HACCP) safety programs, GMP+ feed safety assurance, and ISO 14001 environmental management protocols. Every formulation strictly adheres to FEDIAF guidelines and EU Regulation (EC) No 767/2009.
Yes. Our regulatory department validates all artwork and labeling claims according to destination market laws (EU, UK, Middle East, Asia, Americas). We prepare complete export documentation packages, including Batch Certificates of Analysis (CoA), Veterinary Health Certificates, TRACES documentation, and certificates of free sale.
The standard development cycle spans 4 to 6 weeks for formula development, sample bench trials, and laboratory verification. Once the sample and artwork are locked, standard production and packaging turnaround is typically 3 to 4 weeks depending on raw material procurement lead times.
Yes. In addition to extruded dry kibble and wet cans/pouches, we manufacture functional dental chews engineered for mechanical plaque removal, soft training treats, and veterinary herbal (phyto) liquid or powder supplements designed for targeted organ support.
Built on 11 years of dedicated companion animal nutritional focus, owned manufacturing assets, and full operational control.
Serving international brand partners continuously since 2014 with stable technical leadership and institutional recipe history.
Formulations created, verified, and audited internally by staff veterinarians and qualified animal nutritionists.
Operational redundancy across plants in Spain and Ukraine, guaranteeing supply continuity and optimized logistics costs.
We handle formulation, raw material sourcing, extrusion, retorting, packaging, and export in-house without third-party brokers.
Send our technical team your target therapeutic profile, packaging parameters, and volume projections. We will provide a complete feasibility analysis, cost estimate, and formulation roadmap within 48 hours.